Key Dates

Related Announcements

RFA-MH-22-271, "Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)"

Issued by

National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Mental Health (NIMH) has made a change in the Award Budget section of RFA-MH-22-271, "Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)"

The following change has been made in RFA-MH-22-271

Currently reads:

Part 2. Full Text of Announcement

Section II. Award Information

Award Budget

Application budgets are not limited but need to reflect the actual needs of the proposed project.

Modified to read:

Part 2. Full Text of Announcement

Section II. Award Information

Award Budget

The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Laura M. Rowland, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-480-8335
Email: laura.rowland@nih.gov